We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Abbott Highlights Point of Care Management Solutions

By LabMedica International staff writers
Posted on 31 Jan 2019
Abbott Diagnostics (Lake Forest, IL) highlighted its AegisPOC Point of Care Management Solutions at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. More...
MedLab Middle East is a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe, which encompasses event for every specialism within the laboratory management and diagnostics spectrum.

At MedLab 2019, Abbott highlighted the AegisPOC Point of Care Management Solutions, which has been developed to seamlessly connect point-of-care (POC) devices in the hospital or community with the laboratory. A web-based, open platform, AegisPOC allows users to better manage and share data from their POC devices from multiple brands on one flexible, scalable middleware. AegisPOC provides the ability to integrate POC devices with LIS, HIS, EMR, quality management, user management and other systems.

With AegisPOC in place, the laboratory becomes the hub for the entire system – making it easier to share test results among locations and manage patient test results from all locations. AegisPOC reduces the workload required to manage POC devices. Users can automatically, remotely manage quality control for the whole system, along with automating user certification and re-certification training. AegisPOC brings all POC devices together seamlessly, improving data management capabilities and eliminating the need for multiple propriety middleware.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.